HR 6973
117th Congress
House
Health
Enhanced Access to Affordable Medicines Act of 2022
Introduced: March 8, 2022
Introduced by:
Carter, Earl L. "Buddy"
Republican
· Georgia
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2022
Referred to the Subcommittee on Health.
Mar 8, 2022
Referred to the House Committee on Energy and Commerce.
Mar 8, 2022
Introduced in House
Plain-English summary
Enhanced Access to Affordable Medicines Act of 2022
This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, the brand-name drug is subject to an active patent or exclusivity period and a revised label for the brand-name drug is approved within 90 days (rather than 60 days) of the expiration of the patent or exclusivity period.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1